In Enzyme Function + and K + Role of Na
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Naming Polyatomic Ions and Acids Oxyanions
Oxyanions Naming Polyatomic Ions and Oxyanions Acids Oxyanions- negative ions containing Oxyanions may contain the prefix oxygen. “hypo-”, less than, or “per-”, more than. These have the suffix “-ate” or “-ite” For example - “-ate” means it has more oxygen atoms ClO4 Perchlorate bonded, “-ite” has less - ClO3 Chlorate For example - ClO2 Chlorite 2- SO4 sulfate ClO- Hypochlorite 2- SO3 sulfite Acids Naming acids Naming Acids Certain compounds produce H+ ions in Does it contain oxygen? water, these are called acids. If it does not, it gets the prefix “hydro-” and If it does contain an oxyanion, then the suffix “-ic acid” replace the ending. You can recognize them because the neutral compound starts with “H”. HCl If the ending was “–ate”, add “-ic acid” Hydrochloric acid If the ending was “–ite”, add “-ous acid” For example HCl, H2SO4, and HNO3. HF Don’t confuse a polyatomic ion with a H2SO4 Sulfuric Acid Hydrofluoric acid neutral compound. H2SO3 Sulfurous Acid HCN HCO - is hydrogen carbonate, not an acid. 3 Hydrocyanic acid Examples Examples Nomenclature (naming) of Covalent compounds HNO3 HNO3 Nitric Acid HI HI Hydroiodic acid H3AsO4 H3AsO4 Arsenic Acid HClO2 HClO2 Chlorous Acid 1 Determining the type of bond Covalent bonding is very Covalent bonding is very First, determine if you have an ionic different from ionic naming compound or a covalent compound. similar to ionic naming A metal and a nonmetal will form an You always name the one that is least Ionic names ignored the subscript ionic bond. electronegative first (furthest from because there was only one possible Compounds with Polyatomic ions form fluorine) ratio of elements. -
Magnesium Plays a Salient Role in the Cells
341 Journal of Clinical and Biomedical Sciences Journal homepage: www.jcbsonline.ac.in Review Article Magnesium Plays a Salient Role in the Cells R Deepti1*, G Nalini2 Department of Biochemistry, Sri Muthukumaran Medical college Hospital and Research Institute, Chennai, Tamilnadu, India. Department of Biochemistry, Sri Ramachandra Medical college and Research Institute, Chennai, Tamilnadu, India. Received: 17th October-2014 Accepted: 11th December-2014 Published: 31st –December 2014. Abstract Magnesium is an important macromineral. Major amount of magnesium is present in the bones. Magnesium ab- sorption takes place at the small intestine and magnesium levels are maintained by the kidneys. Magnesium is a fundamen- tal mineral in the mammalian cells. Magnesium acts as a co-factor for many enzymes, especially enzymes involved in carbo- hydrate and lipid metabolism. Magnesium is necessary for muscle contraction by acting as a calcium antagonist, cellular proliferation, apoptosis, immune response, etc. Now a days hypomagnesemia is very commonly seen condition associated with predominant diseases like diabetes, hypertension, cardiovascular diseases, obesity, etc. Several authors have reported that low serum magnesium levels, insulin resistance and hyperlipidemia are interrelated. Hypomagnesemia may play an causative role in the development of diabetes, oxidative stress, thrombosis, atherosclerosis, etc. Hence magnesium impor- tances should be highlighted in the research field. Keywords: hypomagnesemia, hyperlipidemia and atherosclerosis. Introduction Magnesium Homeostasis Magnesium is the fourth most abundant cation and Recommended daily allowance (RDA) for magne- the second most abundant intracellular cation next to potas- sium is 400 mg for men and 300 mg for female. Major sium in the human body.(1,2) sources for magnesium are cereals, beans, leafy vegetables and fish. -
Molecular Dynamics in the Hairpin Ribozyme: Calculational and Experimental Aspects
MOLECULAR DYNAMICS IN THE HAIRPIN RIBOZYME: CALCULATIONAL AND EXPERIMENTAL ASPECTS By Patrick Omondi Ochieng A DISSERTATION Submitted to Michigan State University in partial fulfilment of the requirements for the degree of Biochemistry and Molecular Biology - Doctor of Philosophy 2015 ABSTRACT MOLECULAR DYNAMICS IN THE HAIRPIN RIBOZYME: CALCULATIONAL AND EXPERIMENTAL ASPECTS By Patrick Omondi Ochieng The increasing role of RNA therapy in targeting diseases has inspired several RNA studies and especially structural RNA. Of interest to many scientists is how such RNA can perform their work with limited functional groups available to RNA. The structural versatility of RNA seems to underscore the importance of dynamics in performing several functions. Ribozymes are a good example of structured RNA involved in RNA backbone cleavage with a range of strategies. Hairpin ribozyme invokes domain-domain docking to activate the cleavage process. The major loop rearrangements observed upon docking, as well as the kinetically unfavorable docking process, both argue for conformational selection by pre-organization of the catalytically-competent active site of the hairpin ribozyme. In this thesis, we sought to study the behavior of loop A in sampling the docked-like conformation as evidence for conformational selection. We addressed three major aims which involved (i) understanding the dynamics in loop A using molecular dynamics simulation as a tool for assessing conformational sampling (ii) determining the right loop A construct for NMR studies and resonance assignments for structure determination and (iii) elucidation of fast and slow dynamics in loop A using NMR relaxation techniques. In aim 1 (Chapter 2), molecular dynamics simulation was used to determine conformational heterogeneity in RNA based on alternate base-pair formation within a subset of residues in the loop region of domain A of the hairpin ribozyme. -
And Inter-Protein Couplings of Backbone Motions Underlie
www.nature.com/scientificreports OPEN Intra- and inter-protein couplings of backbone motions underlie protein thiol-disulfde exchange cascade Received: 26 July 2018 Wenbo Zhang1,3, Xiaogang Niu2,3, Jienv Ding1,3,5, Yunfei Hu2,3,6 & Changwen Jin1,2,3,4 Accepted: 6 October 2018 The thioredoxin (Trx)-coupled arsenate reductase (ArsC) is a family of enzymes that catalyzes the Published: xx xx xxxx reduction of arsenate to arsenite in the arsenic detoxifcation pathway. The catalytic cycle involves a series of relayed intramolecular and intermolecular thiol-disulfde exchange reactions. Structures at diferent reaction stages have been determined, suggesting signifcant conformational fuctuations along the reaction pathway. Herein, we use two state-of-the-art NMR methods, the chemical exchange saturation transfer (CEST) and the CPMG-based relaxation dispersion (CPMG RD) experiments, to probe the conformational dynamics of B. subtilis ArsC in all reaction stages, namely the enzymatic active reduced state, the intra-molecular C10–C82 disulfde-bonded intermediate state, the inactive oxidized state, and the inter-molecular disulfde-bonded protein complex with Trx. Our results reveal highly rugged energy landscapes in the active reduced state, and suggest global collective motions in both the C10–C82 disulfde-bonded intermediate and the mixed-disulfde Trx-ArsC complex. Protein thiol-disulfde exchange reactions play fundamental roles in living systems, represented by the thiore- doxin (Trx) and glutaredoxin (Grx) systems that maintain the cytoplasmic reducing environment, the protein DsbA that catalyzes the formation of protein disulfde bonds in bacterial periplasm, as well as the protein disulfde isomerase (PDI) proteins that facilitate correct disulfde bonding1–5. -
Acetic Acid (Activator-3) Is a Potent Activator of AMPK
www.nature.com/scientificreports OPEN 2-[2-(4-(trifuoromethyl) phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent Received: 29 June 2017 Accepted: 6 June 2018 activator of AMPK Published: xx xx xxxx Navneet Bung1, Sobhitha Surepalli2, Sriram Seshadri3, Sweta Patel3, Saranya Peddasomayajula2, Lalith Kumar Kummari 2,5,6, Sireesh T. Kumar4, Phanithi Prakash Babu4, Kishore V. L. Parsa2, Rajamohan Reddy Poondra2, Gopalakrishnan Bulusu1,2 & Parimal Misra2 AMPK is considered as a potential high value target for metabolic disorders. Here, we present the molecular modeling, in vitro and in vivo characterization of Activator-3, 2-[2-(4-(trifuoromethyl) phenylamino)thiazol-4-yl]acetic acid, an AMP mimetic and a potent pan-AMPK activator. Activator-3 and AMP likely share common activation mode for AMPK activation. Activator-3 enhanced AMPK phosphorylation by upstream kinase LKB1 and protected AMPK complex against dephosphorylation by PP2C. Molecular modeling analyses followed by in vitro mutant AMPK enzyme assays demonstrate that Activator-3 interacts with R70 and R152 of the CBS1 domain on AMPK γ subunit near AMP binding site. Activator-3 and C2, a recently described AMPK mimetic, bind diferently in the γ subunit of AMPK. Activator-3 unlike C2 does not show cooperativity of AMPK activity in the presence of physiological concentration of ATP (2 mM). Activator-3 displays good pharmacokinetic profle in rat blood plasma with minimal brain penetration property. Oral treatment of High Sucrose Diet (HSD) fed diabetic rats with 10 mg/kg dose of Activator-3 once in a day for 30 days signifcantly enhanced glucose utilization, improved lipid profles and reduced body weight, demonstrating that Activator-3 is a potent AMPK activator that can alleviate the negative metabolic impact of high sucrose diet in rat model. -
Inhibitors of Pyruvate Carboxylase Tonya N
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by epublications@Marquette Marquette University e-Publications@Marquette Biological Sciences Faculty Research and Biological Sciences, Department of Publications 1-1-2010 Inhibitors of Pyruvate Carboxylase Tonya N. Zeczycki University of Wisconsin - Madison Martin St. Maurice Marquette University, [email protected] Paul V. Attwood University of Western Australia Published version. The Open Enzyme Inhibition Journal, Vol. 3 (2010): 8-26. DOI. © 2010 Bentham Open. Used with permission. This is an open access article licensed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 8 The Open Enzyme Inhibition Journal, 2010, 3, 8-26 Open Access Inhibitors of Pyruvate Carboxylase Tonya N. Zeczycki1, Martin St. Maurice2 and Paul V. Attwood3,* 1Department of Biochemistry, University of Wisconsin, Madison, WI 53726, USA 2Department of Biological Sciences, Marquette University, P.O. Box 1881, Milwaukee, WI 53201-1881, USA 3School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, Crawley, WA6009, Australia Abstract: This review aims to discuss the varied types of inhibitors of biotin-dependent carboxylases, with an emphasis on the inhibitors of pyruvate carboxylase. Some of these inhibitors are physiologically relevant, in that they provide ways of regulating the cellular activities of the enzymes e.g. aspartate and prohibitin inhibition of pyruvate carboxylase. Most of the inhibitors that will be discussed have been used to probe various aspects of the structure and function of these enzymes. They target particular parts of the structure e.g. avidin – biotin, FTP – ATP binding site, oxamate – pyruvate binding site, phosphonoacetate – binding site of the putative carboxyphosphate intermediate. -
Evidence Against Stabilization of the Transition State Oxyanion by a Pka-Perturbed RNA Base in the Peptidyl Transferase Center
Evidence against stabilization of the transition state oxyanion by a pKa-perturbed RNA base in the peptidyl transferase center K. Mark Parnell*, Amy C. Seila†, and Scott A. Strobel*‡§ Departments of *Molecular Biophysics and Biochemistry, †Genetics, and ‡Chemistry, Yale University, 260 Whitney Avenue, New Haven, CT 06520-8114 Edited by Harry F. Noller, University of California, Santa Cruz, CA, and approved July 16, 2002 (received for review April 8, 2002) The crystal structure of the ribosomal 50S subunit from Haloarcula activity, suggesting that 23S and 5S rRNA may constitute the marismortui in complex with the transition state analog CCdA- bulk of the peptidyl transferase center (8). phosphate-puromycin (CCdApPmn) led to a mechanistic proposal The most unambiguous evidence that the active site of the wherein the universally conversed A2451 in the ribosomal active ribosome is comprised of RNA came from the 2.4-Å crystal site acts as an ‘‘oxyanion hole’’ to promote the peptidyl transferase structure of the Haloarcula marismortui 50S ribosomal subunit reaction [Nissen, P., Hansen, J., Ban, N., Moore, P.B., and Steitz, T.A. reported by Ban et al. (9) and Nissen et al. (10). The structure of the (2000) Science 289, 920–929]. In the model, close proximity (3 Å) 50S subunit complexed with the transition-state analog CCdA- between the A2451 N3 and the nonbridging phosphoramidate phosphate-puromycin (CCdApPmn) was vital to this structural oxygen of CCdApPmn suggested that the carbonyl oxyanion identification. CCdApPmn includes the minimal components of formed during the tetrahedral transition state is stabilized by both peptidyl transferase substrates (11). CCdA binds the P site, and hydrogen bonding to the protonated A2451 N3, the pKa of which puromycin binds the A site (Fig. -
Download Author Version (PDF)
MedChemComm Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/medchemcomm Page 1 of 6 Journal Name Medicinal Chemistry Communications Dynamic Article Links ► Cite this: DOI: 10.1039/c0xx00000x www.rsc.org/xxxxxx ARTICLE TYPE Optimizing Glucokinase Activator Binding Kinetics to Lower in vivo Hypoglycemia Risk Manuscript Kris A. Borzilleri ‡ Jeffrey A. Pfefferkorn ╢, Angel Guzman-Perez ¥, Shenping Liu ‡, Xiayang Qiu ‡, Boris A. Chrunyk ‡, Xi Song ‡ Meihua Tu ╢, Kevin J. Filipski ╢, Robert Aiello ±, David R. Derksen ‡, Francis J. ‡ † ± ┴ ┼ ± 5 Bourbonais , James Landro , Patricia Bourassa , Theresa D’Aquila , Levenia Baker , Nicole Barrucci , John Litchfield ‡, Karen Atkinson ‡ Timothy P. Rolph ╢ and Jane M. Withka ‡* Received (in XXX, XXX) Xth XXXXXXXXX 200X, Accepted Xth XXXXXXXXX 200X DOI: 10.1039/b000000x Accepted Activation of glucokinase represents a promising strategy for the treatment of type 2 diabetes; however, 10 drug candidates have failed in clinical trials due to narrow therapeutic index between glucose-lowering efficacy and hypoglycemia. -
Inhibitors of Pyruvate Carboxylase Tonya N
Marquette University e-Publications@Marquette Biological Sciences Faculty Research and Biological Sciences, Department of Publications 1-1-2010 Inhibitors of Pyruvate Carboxylase Tonya N. Zeczycki University of Wisconsin - Madison Martin St. Maurice Marquette University, [email protected] Paul V. Attwood University of Western Australia Published version. The Open Enzyme Inhibition Journal, Vol. 3 (2010): 8-26. DOI. © 2010 Bentham Open. Used with permission. This is an open access article licensed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 8 The Open Enzyme Inhibition Journal, 2010, 3, 8-26 Open Access Inhibitors of Pyruvate Carboxylase Tonya N. Zeczycki1, Martin St. Maurice2 and Paul V. Attwood3,* 1Department of Biochemistry, University of Wisconsin, Madison, WI 53726, USA 2Department of Biological Sciences, Marquette University, P.O. Box 1881, Milwaukee, WI 53201-1881, USA 3School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, Crawley, WA6009, Australia Abstract: This review aims to discuss the varied types of inhibitors of biotin-dependent carboxylases, with an emphasis on the inhibitors of pyruvate carboxylase. Some of these inhibitors are physiologically relevant, in that they provide ways of regulating the cellular activities of the enzymes e.g. aspartate and prohibitin inhibition of pyruvate carboxylase. Most of the inhibitors that will be discussed have been used to probe various aspects of the structure and function of these enzymes. They target particular parts of the structure e.g. avidin – biotin, FTP – ATP binding site, oxamate – pyruvate binding site, phosphonoacetate – binding site of the putative carboxyphosphate intermediate. Keywords: Pyruvate carboxylase, biotin-dependent enzyme, avidin, biotin, nucleotide inhibitors, acetyl coenzyme A, allosteric inhibitors, chlorothricin. -
Light-Controlled Twister Ribozyme with Single-Molecule Detection Resolves RNA Function in Time and Space
Light-controlled twister ribozyme with single-molecule detection resolves RNA function in time and space Arthur Kormana,1,2, Huabing Sunb,1,3, Boyang Huac, Haozhe Yangb, Joseph N. Capilatob, Rakesh Paulb,4, Subrata Panjad,5, Taekjip Hac,e,f, Marc M. Greenbergb,6, and Sarah A. Woodsond,6 aCell, Molecular, Developmental Biology and Biophysics Program, Johns Hopkins University, Baltimore, MD 21218; bDepartment of Chemistry, Johns Hopkins University, Baltimore, MD 21218; cDepartment of Biophysics and Biochemistry, Johns Hopkins University, Baltimore, MD 21205-2185; dT. C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; eDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; and fHoward Hughes Medical Institute, Johns Hopkins University, Baltimore, MD 21205 Edited by Michael F. Summers, University of Maryland, Baltimore County, Baltimore, MD, and approved April 3, 2020 (received for review February 22, 2020) Small ribozymes such as Oryza sativa twister spontaneously cleave which limits their use in dynamics experiments (13). Photosolvolysis their own RNA when the ribozyme folds into its active conforma- reactions, such as those involving p-hydroxyphenacyl protecting tion. The coupling between twister folding and self-cleavage has groups (e.g., ref. 1 and Fig. 1A), release their cargo in less than one been difficult to study, however, because the active ribozyme rap- microsecond (13) and should be useful for probing processes oc- idly converts to product. Here, we describe the synthesis of a pho- curring on the submillisecond timescale. We previously employed tocaged nucleotide that releases guanosine within microseconds a UV-activated variant of 1 to temporally modulate RNA base upon photosolvolysis with blue light. -
In Vitro Selection of Active Hairpin Ribozymes by Sequential RNA-Catalyzed Cleavage Ana Ligation Reactions
Downloaded from genesdev.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage ana ligation reactions Alfredo Berzal-Herranz, Simpson Joseph, and John M. Butke^ Department of Microbiology and Molecular Genetics, Markey Center for Molecular Genetics, The University of Vermont, Burlington, Vermont 05405 USA In vitro selection methods provide rapid and extremely powerful tools for elucidating interactions within and between macromolecules. Here, we describe the development of an in vitro selection procedure that permits the rapid isolation and evaluation of functional hairpin ribozymes from a complex pool of sequence variants containing an extremely low frequency of catalytically proficient molecules. We have used this method to analyze the sequence requirements of two regions of the ribozyme-substrate complex: a 7-nucleotide internal loop within the ribozyme that is essential for catalytic function and substrate sequences surrounding the cleavage-ligation site. Results indicate that only 3 of the 16,384 internal loop variants examined have high cleavage and ligation activity and that the ribozyme has a strong requirement for guanosine immediately 3' to the cleavage-ligation site. [Key Words: Ribozyme; in vitro selection; RNA structure; catalysis] Received September 23, 1991; accepted November 4, 1991. The hairpin ribozyme catalyzes a site-specific RNA selection schemes with natural or surrogate phenotypes cleavage reaction that yields products with 5'-hydroxyl (Price and Cech 1985; Waring et al. 1985) are useful but and 2',3'-cyclic phosphate termini (Feldstein et al. 1989; are difficult to apply to some ribozyme systems, includ Hampel and Tritz 1989; Haseloff and Gerlach 1989). -
GTP Activator and Dntp Substrates of HIV-1 Restriction Factor SAMHD1
GTP activator and dNTP substrates of HIV-1 restriction PNAS PLUS factor SAMHD1 generate a long-lived activated state Erik C. Hansen, Kyle J. Seamon, Shannen L. Cravens, and James T. Stivers1 Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205-2185 Edited by Myron F. Goodman, University of Southern California, Los Angeles, CA, and accepted by the Editorial Board March 26, 2014 (received for review January 27, 2014) The HIV-1 restriction factor sterile α-motif/histidine-aspartate phatases (14). Presumably, degradation to the level of nucleoside domain-containing protein 1 (SAMHD1) is a tetrameric protein that rather than deoxynucleoside diphosphate (dNDP) or deoxy- catalyzes the hydrolysis of all dNTPs to the deoxynucleoside and nucleoside monophosphate (dNMP) is to make the process tripolyphosphate, which effectively depletes the dNTP substrates energetically or kinetically costly to reverse, with the additional of HIV reverse transcriptase. Here, we establish that SAMHD1 is possibility that the neutral nucleoside will be irreversibly trans- activated by GTP binding to guanine-specific activator sites (A1) as ported out of the cell (9). The unusual triphosphohydrolase activity well as coactivation by substrate dNTP binding to a distinct set of of SAMHD1 in quiescent immune cells has received significant nonspecific activator sites (A2). Combined activation by GTP and attention, because HIV-1 and HSV-1 are severely restricted in their dNTPs results in a long-lived tetrameric form of SAMHD1 that ability to infect quiescent cells that have severely depressed dNTP persists for hours, even after activating nucleotides are withdrawn pools, which has been directly linked to SAMHD1 enzymatic ac- from the solution.